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Reciprocal Modulation of Terminal
Sialylation and Bisecting N-Glycans: A New
Axis of Cancer-Cell Glycome Regulation?
Lu et al. (1) have investigated the influence of cellular sialylation on
the GnT-III-mediated regulation of cancer cell metastatic potential.
The authors demonstrated that GnT-III (GlcNAc-bisecting glycosyl-
transferase) overexpression results in a significant reduction of 2,3-
sialylation, with no major alteration of 2,6-sialylation (1). Interest-
ingly, a reciprocal correlation between terminal 2,3-sialylation and
bisected N-glycans has also been recently reported (2). Glycomic
analysis of cancer cells overexpressing the 2,3-sialyltransferase
ST3GAL4 showed that increased terminal 2,3-sialylation is accom-
panied by a substantial loss of bisected N-glycans (2).
This coordinated regulation of 2,3-sialylation by bisecting N-glycans
and vice versa adds a new level of complexity to the regulation of the
cancer cell glycome and raises new questions about the molecular
mechanisms underlying these glycosylation shifts. Noteworthy,
the down-regulation of bisected N-glycans and 2,3-sialylation by
ST3GAL4 and GnT-III, respectively, do not stem from alterations at
the glycosyltransferase transcript levels (1, 2). The supramolecular
organization of the Golgi glycosylation pathways is plastic and can be
altered in cancer cells (3); thus, we can hypothesize that altered local-
ization of the overexpressed glycosyltransferases could functionally
impact the sequential glycan biosynthetic pathways and therefore
interfere with bisecting N-glycans and terminal sialylation.
Increased 2,3-sialylation is associated with malignancy and patients’
poorer prognosis, whereas bisected N-glycans suppress metastization
(4). Moreover, N-glycan branching and sialylation patterns determine
galectin lattice dynamics with critical impact on tumor cell signaling
and definition of aggressiveness features (5). Therefore, deciphering
the mechanisms underlying reciprocal regulation of terminal sialyla-
tion and bisecting N-glycans is fundamental for our understanding of
tumor cell biology.
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